new glp 1 medications Popular GLP-1 may have health benefits that extend beyond weight loss and blood sugar control, a study finds Comparing Ozempic, Wegovy and Other

The mechanism makes physiological sense

Mounjaro is the first and only dual targeted glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist on the market, and has helped patients achieve a body weight loss of over 20 percent in clinical trials

Agosta, M., et al

Many people still equate absence of visible obesity with good health, which is not true in the Indian context, says Dr

This sustained action leads to a far stronger effect on appetite suppression and blood sugar control than what the body can achieve naturally, which is why these medications are highly effective treatments for type 2 diabetes and obesity

You start at 3 mg daily for 30 days